• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

根治性前列腺切除术后生化复发的预后因素

Prognostic factors for the development of biochemical recurrence after radical prostatectomy.

作者信息

Kotb Ahmed F, Elabbady Ahmed A

机构信息

Urology Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt.

出版信息

Prostate Cancer. 2011;2011:485189. doi: 10.1155/2011/485189. Epub 2011 Jun 15.

DOI:10.1155/2011/485189
PMID:22110987
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3200275/
Abstract

Prostate cancer is one of the most common cancers in Western countries and is associated with a considerable risk of mortality. Biochemical recurrence following radical prostatectomy is a relatively common finding, affecting approximately 25% of cases. The aim of our paper was to identify factors that can predict the occurrence of biochemical recurrence, so the patient can be properly counselled pre- and postoperatively. Medline review of the literatures was done followed by a group discussion on the chosen publications and their valuable influence. Preoperative serum total PSA and clinical stage, together with prostatectomy Gleason grade, tumour volume, and perineural and vascular invasions, were the most important variables found to influence outcome.

摘要

前列腺癌是西方国家最常见的癌症之一,且具有相当高的死亡风险。根治性前列腺切除术后的生化复发是一个相对常见的现象,约25%的病例会出现这种情况。我们这篇论文的目的是确定能够预测生化复发发生的因素,以便在术前和术后对患者进行适当的咨询。我们先对医学文献数据库进行了文献综述,随后针对所选出版物及其重要影响进行了小组讨论。术前血清总前列腺特异抗原(PSA)、临床分期,以及前列腺切除标本的 Gleason分级、肿瘤体积、神经周围和血管侵犯,是发现的影响预后的最重要变量。

相似文献

1
Prognostic factors for the development of biochemical recurrence after radical prostatectomy.根治性前列腺切除术后生化复发的预后因素
Prostate Cancer. 2011;2011:485189. doi: 10.1155/2011/485189. Epub 2011 Jun 15.
2
Prostate cancer is highly predictable: a prognostic equation based on all morphological variables in radical prostatectomy specimens.前列腺癌具有高度可预测性:基于根治性前列腺切除术标本中所有形态学变量的预后方程。
J Urol. 2000 Apr;163(4):1155-60. doi: 10.1016/s0022-5347(05)67713-0.
3
Preoperative serum prostate specific antigen does not reflect biochemical failure rates after radical prostatectomy in men with large volume cancers.对于患有大体积癌症的男性,术前血清前列腺特异性抗原不能反映根治性前列腺切除术后的生化失败率。
J Urol. 2000 Nov;164(5):1596-600.
4
Preoperative model for predicting prostate specific antigen recurrence after radical prostatectomy using percent of biopsy tissue with cancer, biopsy Gleason grade and serum prostate specific antigen.使用癌组织活检百分比、活检Gleason分级和血清前列腺特异性抗原预测根治性前列腺切除术后前列腺特异性抗原复发的术前模型。
J Urol. 2004 Jun;171(6 Pt 1):2215-20. doi: 10.1097/01.ju.0000124463.13319.0a.
5
The ability of prostate-specific antigen (PSA) density to predict an upgrade in Gleason score between initial prostate biopsy and prostatectomy diminishes with increasing tumour grade due to reduced PSA secretion per unit tumour volume.前列腺特异性抗原(PSA)密度预测初始前列腺活检和前列腺切除术中 Gleason 评分升级的能力随着肿瘤分级的增加而降低,这是由于单位肿瘤体积的 PSA 分泌减少所致。
BJU Int. 2012 Jul;110(1):36-42. doi: 10.1111/j.1464-410X.2011.10681.x. Epub 2011 Nov 15.
6
Risk factors of positive surgical margin and biochemical recurrence of patients treated with radical prostatectomy: a single-center 10-year report.根治性前列腺切除术患者阳性手术切缘和生化复发的危险因素:单中心 10 年报告。
Chin Med J (Engl). 2011 Apr;124(7):1001-5.
7
Radical prostatectomy for incidental (stage T1a-T1b) prostate cancer: analysis of predictors for residual disease and biochemical recurrence.根治性前列腺切除术治疗偶发性(T1a-T1b期)前列腺癌:残余疾病和生化复发的预测因素分析。
Eur Urol. 2008 Jul;54(1):118-25. doi: 10.1016/j.eururo.2008.02.018. Epub 2008 Feb 26.
8
Tumour growth fraction measured by immunohistochemical staining of Ki67 is an independent prognostic factor in preoperative prostate biopsies with small-volume or low-grade prostate cancer.通过Ki67免疫组化染色测量的肿瘤生长分数是小体积或低级别前列腺癌术前前列腺活检中的一个独立预后因素。
Int J Cancer. 2009 May 1;124(9):2116-23. doi: 10.1002/ijc.24174.
9
Lack of association of prostate carcinoma nuclear grading with prostate specific antigen recurrence after radical prostatectomy.前列腺癌核分级与根治性前列腺切除术后前列腺特异性抗原复发之间无相关性。
J Urol. 2001 Dec;166(6):2193-7.
10
Predicting biochemical recurrence after radical prostatectomy: the role of prognostic grade group and index tumor nodule.预测根治性前列腺切除术后的生化复发:预后分级组和肿瘤结节指数的作用。
Hum Pathol. 2019 Nov;93:6-15. doi: 10.1016/j.humpath.2019.08.012. Epub 2019 Aug 21.

引用本文的文献

1
A Multicenter Machine Learning-Based Predictive Model of Acute Toxicity in Prostate Cancer Patients Undergoing Salvage Radiotherapy (ICAROS Study).一项基于机器学习的多中心预测模型,用于预测接受挽救性放疗的前列腺癌患者的急性毒性(ICAROS研究)。
Cancers (Basel). 2025 Jun 25;17(13):2142. doi: 10.3390/cancers17132142.
2
The potential of gallium-68 prostate-specific membrane antigen positron emission tomography/computed tomography as a main diagnostic tool in prostate cancer staging.镓-68前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描作为前列腺癌分期主要诊断工具的潜力。
Cent European J Urol. 2025;78(1):52-60. doi: 10.5173/ceju.2025.0014. Epub 2025 Mar 14.
3
Contrast-enhanced transrectal ultrasound can reduce collection of unnecessary biopsies when diagnosing prostate cancer and is predictive of biochemical recurrence following a radical prostatectomy in patients with localized prostate cancer.经直肠对比增强超声有助于减少前列腺癌诊断时不必要的活检,且对于局限性前列腺癌患者行根治性前列腺切除术后生化复发具有预测价值。
BMC Urol. 2020 Jul 16;20(1):100. doi: 10.1186/s12894-020-00659-6.
4
The clinicopathologic significance of Notch3 expression in prostate cancer.Notch3表达在前列腺癌中的临床病理意义。
Int J Clin Exp Pathol. 2019 Sep 1;12(9):3535-3541. eCollection 2019.
5
Akt Activation Correlates with Snail Expression and Potentially Determines the Recurrence of Prostate Cancer in Patients at Stage T2 after a Radical Prostatectomy.Akt激活与Snail表达相关,并可能决定T2期前列腺癌患者根治性前列腺切除术后的复发情况。
Int J Mol Sci. 2016 Jul 23;17(8):1194. doi: 10.3390/ijms17081194.
6
Pre- and post-operative nomograms to predict recurrence-free probability in korean men with clinically localized prostate cancer.用于预测韩国临床局限性前列腺癌男性无复发生存概率的术前和术后列线图。
PLoS One. 2014 Jun 17;9(6):e100053. doi: 10.1371/journal.pone.0100053. eCollection 2014.
7
BMI1 polycomb group protein acts as a master switch for growth and death of tumor cells: regulates TCF4-transcriptional factor-induced BCL2 signaling.BMI1 多梳组蛋白作为肿瘤细胞生长和死亡的主开关:调节 TCF4-转录因子诱导的 BCL2 信号通路。
PLoS One. 2013 May 6;8(5):e60664. doi: 10.1371/journal.pone.0060664. Print 2013.
8
Can diffusion-weighted magnetic resonance imaging predict a high Gleason score of prostate cancer?扩散加权磁共振成像能否预测前列腺癌的高 Gleason 评分?
Korean J Urol. 2013 Apr;54(4):234-8. doi: 10.4111/kju.2013.54.4.234. Epub 2013 Apr 16.

本文引用的文献

1
A post-radical-prostatectomy nomogram incorporating new pathological variables and interaction terms for improved prognosis.一种新的包含新病理变量和交互项的前列腺癌根治术后列线图,可改善预后。
BJU Int. 2011 Feb;107(3):389-95. doi: 10.1111/j.1464-410X.2010.09539.x. Epub 2010 Aug 12.
2
Maximum tumor diameter: a simple independent predictor for biochemical recurrence after radical prostatectomy.最大肿瘤直径:前列腺根治性切除术后生化复发的简单独立预测因子。
Prostate Cancer Prostatic Dis. 2010 Sep;13(3):244-7. doi: 10.1038/pcan.2010.17. Epub 2010 Jun 22.
3
Prognostic role of perineural invasion in 239 consecutive patients with pathologically organ-confined prostate cancer.239例病理诊断为器官局限性前列腺癌患者中神经周围侵犯的预后作用
Urol Int. 2010;85(4):396-400. doi: 10.1159/000315491. Epub 2010 May 28.
4
Minimal impact of clinical stage on prostate cancer prognosis among contemporary patients with clinically localized disease.临床分期对当代局限性前列腺癌患者预后的影响较小。
J Urol. 2010 Jul;184(1):114-9. doi: 10.1016/j.juro.2010.03.025. Epub 2010 May 15.
5
Focal positive surgical margins decrease disease-free survival after radical prostatectomy even in organ-confined disease.局限性前列腺癌根治术后切缘阳性降低无病生存率,即使是在器官局限性疾病中。
Urology. 2010 Nov;76(5):1212-6. doi: 10.1016/j.urology.2009.08.088. Epub 2010 Jan 27.
6
Definition of biochemical recurrence after radical prostatectomy does not substantially impact prognostic factor estimates.根治性前列腺切除术后生化复发的定义并不会显著影响预后因素的估计。
J Urol. 2010 Mar;183(3):984-9. doi: 10.1016/j.juro.2009.11.027. Epub 2010 Jan 18.
7
Long-term data on the survival of patients with prostate cancer treated with radical prostatectomy in the prostate-specific antigen era.在前列腺特异性抗原时代接受根治性前列腺切除术治疗的前列腺癌患者的生存长期数据。
BJU Int. 2010 Jul;106(1):37-43. doi: 10.1111/j.1464-410X.2009.09134.x. Epub 2009 Dec 11.
8
Comparison of prostate cancer tumor volume and percent cancer in prediction of biochemical recurrence and cancer specific survival.比较前列腺癌肿瘤体积和肿瘤百分比对生化复发和癌症特异性生存的预测。
Urol Oncol. 2011 May-Jun;29(3):314-8. doi: 10.1016/j.urolonc.2009.06.017. Epub 2009 Oct 17.
9
The burden of prostate cancer in Canada.加拿大前列腺癌的负担。
Can Urol Assoc J. 2009 Jun;3(3 Suppl 2):S92-S100.
10
Cancer statistics, 2009.2009年癌症统计数据。
CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49. doi: 10.3322/caac.20006. Epub 2009 May 27.